Shangrong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shangrong Li has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Dijun Du
ShanghaiTech University
3 shared publications - Jinliang Guo
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
3 shared publications - Tuerxunjiang Maimaiti
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
3 shared publications - Yanjie Chao
The Center for Microbes, Development and Health, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China
3 shared publications Zhaojun Zhong
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
3 shared publications- Ben F. Luisi
Department of Biochemistry, University of Cambridge
2 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A model for drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly
Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the cell envelope, often via an indirect stepwise process. The major facilitator superfamily (MFS)-type tripartite efflux pumps use proton electrochemical gradient to extrude drugs in diverse bacterial species, but the architecture of the assembly and structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a distinct, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1 and contacts that are essential for the pump assembly. Key residues involved in drug transport are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The structural and functional data support a model for one-step drug transport by the MFS pump across the entire envelope of Gram-negative bacteria.
- 16 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA model for drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly
Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the cell envelope, often via an indirect stepwise process. The major facilitator superfamily (MFS)-type tripartite efflux pumps use proton electrochemical gradient to extrude drugs in diverse bacterial species, but the architecture of the assembly and structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a distinct, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1 and contacts that are essential for the pump assembly. Key residues involved in drug transport are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The structural and functional data support a model for one-step drug transport by the MFS pump across the entire envelope of Gram-negative bacteria.
- Open Access
- 13 February 2025
- Published by Springer Nature in Research Square
One-step drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly
Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the envelope, often via an indirect stepwise procedure. The major facilitator superfamily (MFS)-type tripartite efflux pumps and type I secretion systems likely employ a direct one-step transport approach, but the structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a unique, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1. This structure reveals two critical subdomains AssA and AssB that are essential for the pump assembly. Key residues involved in drug recognition, proton translocation and coupling are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The delineation of the complete translocation pathway unravels the one-step drug transport mechanism of the MFS pump across the entire envelope of Gram-negative bacteria.
- 13 February 2025
- Published by Springer Nature in Research Square
Open AccessOne-step drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly
Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the envelope, often via an indirect stepwise procedure. The major facilitator superfamily (MFS)-type tripartite efflux pumps and type I secretion systems likely employ a direct one-step transport approach, but the structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a unique, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1. This structure reveals two critical subdomains AssA and AssB that are essential for the pump assembly. Key residues involved in drug recognition, proton translocation and coupling are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The delineation of the complete translocation pathway unravels the one-step drug transport mechanism of the MFS pump across the entire envelope of Gram-negative bacteria.
- Open Access
- 3 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Structural transition of GP64 triggered by a pH-sensitive multi-histidine switch
The fusion of viruses with cellular membranes is a critical step in the life cycle of enveloped viruses. This process is facilitated by viral fusion proteins, many of which are conformationally pH-sensitive. The specifics of how changes in pH initiate this fusion have remained largely elusive. This study presents the cryo-electron microscopy (cryo-EM) structures of a prototype class III fusion protein, GP64, in its prefusion and early intermediate states, revealing the structural intermediates accompanying the membrane fusion process. The structures identify the involvement of a pH-sensitive switch, comprising H23, H245, and H304, in sensing the low pH that triggers the initial step of membrane fusion. The pH sensing role of this switch is corroborated by assays of cell-cell syncytium formation and dual dye-labeling. The findings demonstrate that coordination between multiple histidine residues acts as a pH sensor and activator. The involvement of a multi-histidine switch in viral fusion is applicable to fusogens of human-infecting thogotoviruses and other viruses, which could lead to strategies for developing anti-viral therapies and vaccines.
- 3 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessStructural transition of GP64 triggered by a pH-sensitive multi-histidine switch
The fusion of viruses with cellular membranes is a critical step in the life cycle of enveloped viruses. This process is facilitated by viral fusion proteins, many of which are conformationally pH-sensitive. The specifics of how changes in pH initiate this fusion have remained largely elusive. This study presents the cryo-electron microscopy (cryo-EM) structures of a prototype class III fusion protein, GP64, in its prefusion and early intermediate states, revealing the structural intermediates accompanying the membrane fusion process. The structures identify the involvement of a pH-sensitive switch, comprising H23, H245, and H304, in sensing the low pH that triggers the initial step of membrane fusion. The pH sensing role of this switch is corroborated by assays of cell-cell syncytium formation and dual dye-labeling. The findings demonstrate that coordination between multiple histidine residues acts as a pH sensor and activator. The involvement of a multi-histidine switch in viral fusion is applicable to fusogens of human-infecting thogotoviruses and other viruses, which could lead to strategies for developing anti-viral therapies and vaccines.